Dr. Juan Luis Vásquez is a leading urologist, researcher, and academic specializing in urothelial cancer. He is Senior Consultant and Chief of the Urothelial Cancer Team at Zealand University Hospital Roskilde and Associate Professor at the University of Copenhagen. His vision is to make bladder cancer management more patient-friendly and cost-effective through innovation and research.
With a PhD in electrochemotherapy for bladder cancer, Dr. Vásquez has contributed 26 peer-reviewed publications (H-index: 12), secured a granted patent for a device capable of performing transurethral electroporation, and attracted over €270,000 in research funding. He supervises three PhD students, focusing on novel treatment strategies.
He holds key leadership roles, including Chair of the EAU Young Urologist Office, Board Member of the European Association of Urology, Board of European Urology Scholarship Program, co-chair of the bladder cancer group at the EAU section of Endourology and Board of the Danish Bladder Cancer Group. A dedicated educator, he has organized 80+ international symposia, created the award-winning EAU Talent Incubator Programme, and delivered 65+ invited talks at global conferences.
Through his research, mentorship, and leadership, Dr. Vásquez continues to drive advancements in bladder cancer treatment, aiming for more accessible and effective care.
Selected publications from PubMed
Reply to Editorial Comment on "The Influence of Virtual Reality on Pain and Anxiety During Flexible Cystoscopy".
Leinum LR, Bach SW, Hedegaard P, Vásquez JL
Urology. 2026 Aug 22 pii: S0090-4295(26)00520-0. doi: 10.1016/j.urology.2026.08.015.
Histopathological Advantages of En Bloc Resection in Non-muscle-invasive Bladder Cancer: A Multinational Randomised Controlled Clinical Trial.
Nielsen NK, Milling RV, Hjort PB, Vásquez JL, Haug ES, Sørensen FE, Olsen KØ, Fabrin K, Vjaters E, Rudlang TM, Sepp T, Nurminen P, Geertsen L, Lam GW, Jakobsen JK, Graugaard-Jensen C, Stifter-Vretenar S, Jensen JB, Kingo PS
Eur Urol Open Sci. 2026 Aug;90:69-76 doi: 10.1016/j.euros.2026.06.005.
Symptom-guided reduction of BCG dwell time: findings from the north-REG randomized trial.
Munk L, Hyldgaard JM, Kumasegaram V, Milling RV, Brandt SB, Vásquez JL, Fabrin K, Lam GW, Bro L, Gudjonsson S, Ströck V, Jerlsström T, Thiel T, Lindgren MS, Jensen JB, Graugaard-Jensen C
BJU Int. 2026 Jul 31 doi: 10.1111/bju.70396.
The Influence of Virtual Reality on Pain and Anxiety During Flexible Cystoscopy.
Leinum LR, Bach SW, Hedegaard P, Vásquez JL
Urology. 2026 Jul 11 pii: S0090-4295(26)00441-3. doi: 10.1016/j.urology.2026.07.005.
Re: Jethro C.C. Kwong, Zizo Al-Daqqaq, Yashan Chelliahpillai, et al. Development and International Evaluation of an Artificial Intelligence-based Model (PROGRxN-BCa) Using the World Health Organization 2004/2022 Grading System to Predict Progression Risk and Improve Substratification for Non-muscle-invasive Bladder Cancer. Eur Urol. 2026;89:404-413.
Cold KM, Vásquez JL
Eur Urol. 2026 Jul;90(1):e16-e17 doi: 10.1016/j.eururo.2026.01.036.
Help your network discover Dr. Juan Luis Vásquez's clinical expertise.
